 Neurofibromatoses
"Neurofibromatoses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)
| Descriptor ID |
D017253
|
| MeSH Number(s) |
C04.557.580.600.580.590 C04.700.645 C10.562.600 C10.574.500.549 C16.320.400.560 C16.320.700.645
|
| Concept/Terms |
Neurofibromatoses- Neurofibromatoses
- Neurofibromatosis
- Neurofibromatosis Syndrome
- Neurofibromatosis Syndromes
- Syndrome, Neurofibromatosis
- Syndromes, Neurofibromatosis
- Multiple Neurofibromas
- Multiple Neurofibroma
- Neurofibroma, Multiple
- Neurofibromas, Multiple
Neurofibromatosis 3- Neurofibromatosis 3
- Neurofibromatosis 3s
- Neurofibromatosis Type 3
- Neurofibromatosis Type 3s
- Type 3, Neurofibromatosis
|
Below are MeSH descriptors whose meaning is more general than "Neurofibromatoses".
Below are MeSH descriptors whose meaning is more specific than "Neurofibromatoses".
This graph shows the total number of publications written about "Neurofibromatoses" by people in this website by year, and whether "Neurofibromatoses" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurofibromatoses" by people in Profiles.
-
Klein-Tasman BP, Lee K, Thompson HL, Janusz J, Payne JM, Pardej S, de Blank P, Kennedy T, Janke KM, Castillo AD, Walsh KS. Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis. Neurology. 2021 08 17; 97(7 Suppl 1):S81-S90.
-
Janusz JA, Klein-Tasman BP, Payne JM, Wolters PL, Thompson HL, Martin S, de Blank P, Ullrich N, Del Castillo A, Hussey M, Hardy KK, Haebich K, Rosser T, Toledo-Tamula MA, Walsh KS. Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 2021 08 17; 97(7 Suppl 1):S73-S80.
-
Adams RB, Dudley JT, Struessel TS. Physical therapy to address fall risk in an individual with neurofibromatosis. Physiother Theory Pract. 2022 Nov; 38(11):1823-1831.
-
Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE, Tabori U. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1. Clin Cancer Res. 2017 Jun 15; 23(12):e46-e53.
-
Khodaee M. Painless cutaneous nodules. J Fam Pract. 2012 Aug; 61(8):489-91.
-
Karol LA, Haideri NF, Halliday SE, Smitherman TB, Johnston CE. Gait analysis and muscle strength in children with congenital pseudarthrosis of the tibia: the effect of treatment. J Pediatr Orthop. 1998 May-Jun; 18(3):381-6.
-
Krupski WC, Selzman CH, Whitehill TA. Unusual causes of mesenteric ischemia. Surg Clin North Am. 1997 Apr; 77(2):471-502.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|